CBP Mediates NF-κB-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter

REFERENCES

• Adamson AD, et al. 2008. Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling. Endocrinology 149: 687–694.
   PubMedGoogle Scholar
• Bodine PV, Harris HA, Komm BS. 1999. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts. Endocrinology 140: 2439–2451.
   PubMedGoogle Scholar
• Brower-Toland B, et al. 2005. Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes. J. Mol. Biol. 346: 135–146.
   PubMed Web of Science ®Google Scholar
• Cakouros D, et al. 2001. A NF-kappa B/Sp1 region is essential for chromatin remodeling and correct transcription of a human granulocyte-macrophage colony-stimulating factor transgene. J. Immunol. 167: 302–310.
   PubMedGoogle Scholar
• Carroll JS, et al. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33–43.
   PubMed Web of Science ®Google Scholar
• Carroll JS, et al. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38: 1289–1297.
   PubMed Web of Science ®Google Scholar
• Cerciat M, Unkila M, Garcia-Segura LM, Arevalo MA. 2010. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 58: 93–102.
   PubMed Web of Science ®Google Scholar
• Chang EC, Frasor J, Komm B, Katzenellenbogen BS. 2006. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 147: 4831–4842.
   PubMed Web of Science ®Google Scholar
• Chen LF, Mu Y, Greene WC. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21: 6539–6548.
   PubMed Web of Science ®Google Scholar
• Chu S, Nishi Y, Yanase T, Nawata H, Fuller PJ. 2004. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells. Mol. Endocrinol. 18: 1919–1928.
   PubMed Web of Science ®Google Scholar
• Clapier CR, Cairns BR. 2009. The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78: 273–304.
   PubMed Web of Science ®Google Scholar
• Clarke DL, et al. 2010. TNFalpha and IFNgamma synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kappaB, and the transcriptional coactivator CREB-binding protein. J. Biol. Chem. 285: 29101–29110.
   PubMed Web of Science ®Google Scholar
• Cvoro A, et al. 2006. Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol. Cell 21: 555–564.
   PubMedGoogle Scholar
• Feldman I, Feldman GM, Mobarak C, Dunkelberg JC, Leslie KK. 2007. Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha. Am. J. Obstet. Gynecol. 196: 394.e1–394.e13.
   PubMedGoogle Scholar
• Frasor J, et al. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562–4574.
   PubMed Web of Science ®Google Scholar
• Frasor J, et al. 2009. Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res. 69: 8918–8925.
   PubMed Web of Science ®Google Scholar
• Frasor J, Weaver AE, Pradhan M, Mehta K. 2008. Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines. Endocrinology 149: 6272–6279.
   PubMedGoogle Scholar
• Gruber CJ, Gruber DM, Gruber IM, Wieser F, Huber JC. 2004. Anatomy of the estrogen response element. Trends Endocrinol. Metab. 15: 73–78.
   PubMedGoogle Scholar
• Hah N, et al. 2011. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145: 622–634.
   PubMed Web of Science ®Google Scholar
• Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK. 2000. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology 141: 3403–3411.
   PubMed Web of Science ®Google Scholar
• Heldring N, et al. 2011. Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Mol. Endocrinol. 25: 564–574.
   PubMedGoogle Scholar
• Holloway AF, Rao S, Chen X, Shannon MF. 2003. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J. Exp. Med. 197: 413–423.
   PubMedGoogle Scholar
• Holloway JN, Murthy S, El-Ashry D. 2004. A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-alpha down-regulation in breast cancer cells: the role of nuclear factor-kappaB. Mol. Endocrinol. 18: 1396–1410.
   PubMedGoogle Scholar
• Hong SY, et al. 2000. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40-, and Epstein-Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J. Biol. Chem. 275: 18022–18028.
   PubMed Web of Science ®Google Scholar
• Hua B, et al. 2006. A splice variant of stress response gene ATF3 counteracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator. J. Biol. Chem. 281: 1620–1629.
   PubMedGoogle Scholar
• Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. 2011. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43: 27–33.
   PubMed Web of Science ®Google Scholar
• Jakacka M, et al. 2002. An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16: 2188–2201.
   PubMed Web of Science ®Google Scholar
• Kalaitzidis D, Gilmore TD. 2005. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab. 16: 46–52.
   PubMed Web of Science ®Google Scholar
• Kim MY, Woo EM, Chong YT, Homenko DR, Kraus WL. 2006. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol. 20: 1479–1493.
   PubMedGoogle Scholar
• King AE, et al. 2010. An additive interaction between the NFkappaB and estrogen receptor signalling pathways in human endometrial epithelial cells. Hum. Reprod. 25: 510–518.
   PubMedGoogle Scholar
• Kininis M, et al. 2007. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol. Cell. Biol. 27: 5090–5104.
   PubMedGoogle Scholar
• Klinge CM, Jernigan SC, Smith SL, Tyulmenkov VV, Kulakosky PC. 2001. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha. Mol. Cell Endocrinol. 174: 151–166.
   PubMed Web of Science ®Google Scholar
• Kushner PJ, et al. 2000. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74: 311–317.
   PubMed Web of Science ®Google Scholar
• Lalmansingh AS, Uht RM. 2008. Estradiol regulates corticotropin-releasing hormone gene (crh) expression in a rapid and phasic manner that parallels estrogen receptor-alpha and -beta recruitment to a 3′,5′-cyclic adenosine 5′-monophosphate regulatory region of the proximal crh promoter. Endocrinology 149: 346–357.
   PubMed Web of Science ®Google Scholar
• Lin CY, et al. 2007. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 3: e87.
   PubMed Web of Science ®Google Scholar
• Mahmoodzadeh S, et al. 2009. Nuclear factor-kappaB regulates estrogen receptor-alpha transcription in the human heart. J. Biol. Chem. 284: 24705–24714.
   PubMedGoogle Scholar
• Mao C, et al. 2008. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells. J. Biol. Chem. 283: 12819–12830.
   PubMed Web of Science ®Google Scholar
• Mason CE, et al. 2010. Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements. Nucleic Acids Res. 38: 2355–2368.
   PubMedGoogle Scholar
• McDevitt MA, et al. 2008. New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice. Mol. Cell Endocrinol. 290: 24–30.
   PubMed Web of Science ®Google Scholar
• Ndlovu N, et al. 2009. Hyperactivated NF-κB and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol. Cell. Biol. 29: 5488–5504.
   PubMed Web of Science ®Google Scholar
• Nettles KW, et al. 2008. CBP is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. Mol. Endocrinol. 22: 263–272.
   PubMedGoogle Scholar
• Nissen LJ, Gelly JC, Hipskind RA. 2001. Induction-independent recruitment of CREB-binding protein to the c-fos serum response element through interactions between the bromodomain and Elk-1. J. Biol. Chem. 276: 5213–5221.
   PubMedGoogle Scholar
• Pradhan M, Bembinster LA, Baumgarten SC, Frasor J. 2010. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NFκB cooperativity at adjacent response elements. J. Biol. Chem. 285: 31100–31106.
   PubMed Web of Science ®Google Scholar
• Quandt K, Frech K, Karas H, Wingender E, Werner T. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23: 4878–4884.
   PubMed Web of Science ®Google Scholar
• Rubio MF, et al. 2006. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25: 1367–1377.
   PubMed Web of Science ®Google Scholar
• Ryser S, Massiha A, Piuz I, Schlegel W. 2004. Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter. Biochem. J. 378: 473–484.
   PubMed Web of Science ®Google Scholar
• Safe S, Kim K. 2008. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 41: 263–275.
   PubMed Web of Science ®Google Scholar
• Sorlie T, et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98: 10869–10874.
   PubMed Web of Science ®Google Scholar
• Sorlie T, et al. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U. S. A. 100: 8418–8423.
   PubMed Web of Science ®Google Scholar
• Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon ROIII. 2000. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells. Circ. Res. 87: 1006–1011.
   PubMedGoogle Scholar
• Stanculescu A, et al. 2010. Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner. Horm. Cancer 1: 127–135.
   PubMedGoogle Scholar
• Vega VB, et al. 2006. Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites. Genome Biol. 7: R82.
   PubMedGoogle Scholar
• Wissink S, van der Burg B, Katzenellenbogen BS, van der Saag PT. 2001. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Mol. Endocrinol. 15:543–552.
   PubMedGoogle Scholar